Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 4/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | TSHR | P16473 | 4/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.59 |
| ▸ | NPC1 | O15118 | 7/20 | 0.55 |
| ▸ | RAB9A | P51151 | 6/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.55 |
| ▸ | MEN1 | O00255 | 5/20 | 0.55 |
| ▸ | POLB | P06746 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | CA12 | O43570 | 2/20 | 0.53 |
| ▸ | CA2 | P00918 | 2/20 | 0.53 |
| ▸ | CA9 | Q16790 | 2/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.53 |
| ▸ | CASP3 | P42574 | 2/20 | 0.53 |
| ▸ | SENP8 | Q96LD8 | 2/20 | 0.53 |
| ▸ | SENP7 | Q9BQF6 | 2/20 | 0.53 |
| ▸ | SENP6 | Q9GZR1 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL532257 | 1.00 | MAPK1 (0.59) | MAPK1ALDH1A1TSHRTDP1HSD17B10 | |
| SCHEMBL194965 | 0.87 | ALDH1A1 (0.58) | MAPK1ALDH1A1TSHRTDP1HSD17B10 | |
| SCHEMBL3217829 | 0.82 | ALDH1A1 (0.81) | MAPK1ALDH1A1TSHRTDP1HSD17B10 | |
| SCHEMBL3217836 | 0.82 | ALDH1A1 (0.81) | MAPK1ALDH1A1TSHRTDP1HSD17B10 | |
| SCHEMBL1405466 | 0.82 | ALDH1A1 (0.81) | MAPK1ALDH1A1TSHRTDP1HSD17B10 | |
| SCHEMBL3217840 | 0.82 | ALDH1A1 (0.81) | MAPK1ALDH1A1TSHRTDP1HSD17B10 | |
| SCHEMBL1405467 | 0.82 | ALDH1A1 (0.81) | MAPK1ALDH1A1TSHRTDP1HSD17B10 | |
| SCHEMBL7787563 | 0.80 | TSHR (0.59) | MAPK1ALDH1A1TSHRTDP1HSD17B10 | |
| SCHEMBL6652098 | 0.80 | TSHR (0.59) | MAPK1ALDH1A1TSHRTDP1HSD17B10 | |
| SCHEMBL8661516 | 0.80 | ALDH1A1 (0.59) | MAPK1ALDH1A1TSHRTDP1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 155 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11396522-B2 | Bis-acetal-based substrates for imaging exo-glycosidase activity | ALECTOS THERAPEUTICS INC. (CA) | 2022-07-26 | — | — | US | claimed |
| US-10739331-B2 | OMA1 activity assay | BIOVENTURES, LLC (US) | 2020-08-11 | — | — | US | claimed |
| US-20200207800-A1 | BIS-ACETAL-BASED SUBSTRATES FOR IMAGING EXO-GLYCOSIDASE ACTIVITY | ALECTOS THERAPEUTICS INC. (CA) | 2020-07-02 | — | — | US | claimed |
| US-20200182889-A1 | CHEMILUMINESCENT BIOSENSOR FOR DETECTING COAGULATION FACTORS | LEE JI HOON (US) | 2020-06-11 | — | — | US | claimed |
| US-20190049430-A1 | NOVEL OMA1 ACTIVITY ASSAY | BIOVENTURES, LLC | 2019-02-14 | — | — | US | claimed |
| WO-2018229663-A1 | BIS-ACETAL-BASED SUBSTRATES FOR IMAGING EXO-GLYCOSIDASE ACTIVITY | ALECTOS THERAPEUTICS INC. (CA) | 2018-12-20 | — | — | WO | claimed |
| US-7662942-B2 | Oligonucleotide probes containing two labels useful in hybridization assays | Elitech Holdings, B.V. (NL) | 2010-02-16 | — | — | US | claimed |
| EP-1430147-A4 | FLUORESCENT QUENCHING DETECTION REAGENTS AND METHODS | EPOCH BIOSCIENCES INC (US) | 2008-06-25 | — | — | EP | claimed |
| US-6955891-B2 | Reagents for assaying Bacillus anthracis lethal factor protease | MERCK & CO., INC. (US) | 2005-10-18 | — | — | US | claimed |
| EP-1430147-A1 | FLUORESCENT QUENCHING DETECTION REAGENTS AND METHODS | Epoch Biosciences, Inc. (US) | 2004-06-23 | — | — | EP | claimed |
| WO-2002099141-A9 | FLUORESCENT QUENCHING DETECTION REAGENTS AND METHODS | EPOCH BIOSCIENCES INC (US) | 2004-05-27 | — | — | WO | claimed |
| US-20040081959-A9 | Using oligonucleotide detectors; hybridization analyzing | EPOCH BIOSCIENCES, INC. (US) | 2004-04-29 | — | — | US | claimed |
| US-20040019182-A1 | Reagents and methods for assaying Bacillus anthracis lethal factor protease | MERCK & CO., INC. | 2004-01-29 | — | — | US | claimed |
| WO-2003073066-A2 | REAGENTS AND METHODS FOR ASSAYING BACILLUS ANTHRACIS LETHAL FACTOR PROTEASE | MERCK & CO., INC. (US) | 2003-09-04 | — | — | WO | claimed |
| US-20030096254-A1 | Enhancing resonance ability of oligonuclotide probes for use in hybridization assays; gene expression | EPOCH BIOSCIENCES, INC. (US) | 2003-05-22 | — | — | US | claimed |
| WO-2002099141-A1 | FLUORESCENT QUENCHING DETECTION REAGENTS AND METHODS | EPOCH BIOSCIENCES, INC. (US) | 2002-12-12 | — | — | WO | claimed |
| US-20020155484-A1 | Fluorescent quenching detection reagents and methods | EPOCH PHARMACEUTICALS, INC. (US) | 2002-10-24 | — | — | US | claimed |
| US-6194143-B1 | MEASUREMENT ACTIVITY BY MONITORING SUBSTRATE CLEAVAGE | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2001-02-27 | — | — | US | claimed |
| US-5917012-A | PEPTIDE DERIVATIVES USEFUL FOR THE MEASUREMENT OF PROTEIN PHOSPHATASE ACTIVITY; CONTAINING A FLUORESCENT GROUP, A QUENCHING GROUP AND A PHOSPHORIC ACID GROUP | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 1999-06-29 | — | — | US | claimed |
| EP-3867643-B1 | REAL TIME WESTERN BLOT ASSAYS UTILIZING FLUORESCENCE RESONANCE ENERGY TRANSFER (FRET) | MOLECULAR DEVICES AUSTRIA GMBH (AT) | 2024-05-08 | — | — | EP | disclosed |
| WO-2023100158-A9 | SUBSTRATES FOR IMAGING GLUCOCEREBROSIDASE ACTIVITY | SIMON FRASER UNIVERSITY (CA) | 2023-12-07 | — | — | WO | disclosed |
| US-20230236177-A1 | REAL TIME WESTERN BLOT ASSAYS UTILIZING FLUORESCENCE RESONANCE ENERGY TRANSFER (FRET) | Molecular Devices (Austria) GmbH (AT) | 2023-07-27 | — | — | US | disclosed |
| WO-2023100158-A1 | SUBSTRATES FOR IMAGING GLUCOCEREBROSIDASE ACTIVITY | SIMON FRASER UNIVERSITY (CA) | 2023-06-08 | — | — | WO | disclosed |
| US-11604186-B2 | Real time western blot assays utilizing fluorescence resonance energy transfer (FRET) | Molecular Devices (Austria) GmbH (AT) | 2023-03-14 | — | — | US | disclosed |
| US-20230022745-A1 | Methods for Labeling a Population of RNA Molecules | NEW ENGLAND BIOLABS, INC. (US) | 2023-01-26 | — | — | US | disclosed |
| US-11396522-B2 | Bis-acetal-based substrates for imaging exo-glycosidase activity | ALECTOS THERAPEUTICS INC. (CA) | 2022-07-26 | — | — | US | disclosed |
| US-11040976-B2 | Substrate selective inhibitors of insulin-degrading enzyme (IDE) and uses thereof | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2021-06-22 | — | — | US | disclosed |
| US-10739331-B2 | OMA1 activity assay | BIOVENTURES, LLC (US) | 2020-08-11 | — | — | US | disclosed |
| US-20200207800-A1 | BIS-ACETAL-BASED SUBSTRATES FOR IMAGING EXO-GLYCOSIDASE ACTIVITY | ALECTOS THERAPEUTICS INC. (CA) | 2020-07-02 | — | — | US | disclosed |
| US-20200182889-A1 | CHEMILUMINESCENT BIOSENSOR FOR DETECTING COAGULATION FACTORS | LEE JI HOON (US) | 2020-06-11 | — | — | US | disclosed |
| WO-2020079638-A1 | REAL TIME WESTERN BLOT ASSAYS UTILIZING FLUORESCENCE RESONANCE ENERGY TRANSFER (FRET) | Molecular Devices (Austria) GmbH (AT) | 2020-04-23 | — | — | WO | disclosed |
| US-20200124591-A1 | Real Time Western Blot Assays Utilizing Fluorescence Resonance Energy Transfer (FRET) | Molecular Devices (Austria) GmbH (AT) | 2020-04-23 | — | — | US | disclosed |
| EP-3155406-B1 | OPTICAL BIOSENSOR | VOELCKER NICOLAS HANS (AU) | 2019-09-18 | — | — | EP | disclosed |
| EP-3485282-A1 | CHEMILUMINESCENT BIOSENSOR FOR DETECTING COAGULATION FACTORS | Lee, Ji Hoon (US) | 2019-05-22 | — | — | EP | disclosed |
| US-10234390-B2 | Optical biosensor | Voelcker, Nicholas H. (AU) | 2019-03-19 | — | — | US | disclosed |
| US-20190049430-A1 | NOVEL OMA1 ACTIVITY ASSAY | BIOVENTURES, LLC | 2019-02-14 | — | — | US | disclosed |
| US-20190016723-A9 | SUBSTRATE SELECTIVE INHIBITORS OF INSULIN-DEGRADING ENZYME (IDE) AND USES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2019-01-17 | — | — | US | disclosed |
| WO-2018229663-A1 | BIS-ACETAL-BASED SUBSTRATES FOR IMAGING EXO-GLYCOSIDASE ACTIVITY | ALECTOS THERAPEUTICS INC. (CA) | 2018-12-20 | — | — | WO | disclosed |
| US-20180195061-A1 | Methods for Labeling a Population of RNA Molecules | NEW ENGLAND BIOLABS, INC. (US) | 2018-07-12 | — | — | US | disclosed |
| US-20180194768-A1 | SUBSTRATE SELECTIVE INHIBITORS OF INSULIN DEGRADING ENZYME (IDE) AND USES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2018-07-12 | — | — | US | disclosed |
| WO-2018014025-A1 | CHEMILUMINESCENT BIOSENSOR FOR DETECTING COAGULATION FACTORS | LEE JI HOON (US) | 2018-01-18 | — | — | WO | disclosed |
| WO-2018005229-A1 | IN FEED ASSAY OF MICROBIAL PROTEASES USING PEPTIDE SUBSTRATES | DUPONT NUTRITION BIOSCIENCES APS (DK) | 2018-01-04 | — | — | WO | disclosed |
| EP-2558482-B1 | ENGINEERED PLANT CYSTEINE PROTEASES AND THEIR USES | JANSSEN BIOTECH INC (US) | 2017-09-27 | — | — | EP | disclosed |
| US-20170108437-A1 | Optical Biosensor | VOELCKER, Nicolas H. (AU) | 2017-04-20 | — | — | US | disclosed |
| EP-3155406-A1 | OPTICAL BIOSENSOR | University Of South Australia (AU) | 2017-04-19 | — | — | EP | disclosed |
| WO-2016172631-A2 | SUBSTRATE SELECTIVE INHIBITORS OF INSULIN-DEGRADING ENZYME (IDE) AND USES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2016-10-27 | — | — | WO | disclosed |
| EP-2247575-B1 | CYCLIC INDOLE-3-CARBOXAMIDES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS | SANOFI SA (FR) | 2016-03-23 | — | — | EP | disclosed |
| US-20160046981-A1 | Compositions and Methods for the Transfer of a Hexosamine to a Modified Nucleotide in a Nucleic Acid | NEW ENGLAND BIOLABS, INC. (US) | 2016-02-18 | — | — | US | disclosed |
| WO-2015188215-A1 | OPTICAL BIOSENSOR | UNIVERSITY OF SOUTH AUSTRALIA (AU) | 2015-12-17 | — | — | WO | disclosed |
| US-9200260-B2 | Compositions and methods for the transfer of a hexosamine to a modified nucleotide in a nucleic acid | NEW ENGLAND BIOLABS, INC. (US) | 2015-12-01 | — | — | US | disclosed |
| EP-1730298-B1 | SPECIFIC SUBSTRATES FOR O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE | EPFL ECOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE (CH) | 2015-11-11 | — | — | EP | disclosed |
| EP-1991691-B1 | DETECTION OF ANTHRAX PATHOGENICITY FACTORS | US GOVERNMENT (US) | 2015-11-04 | — | — | EP | disclosed |
| EP-2848696-A1 | Caspase-1 imaging probes | Sanofi-Aventis Deutschland GmbH (DE) | 2015-03-18 | — | — | EP | disclosed |
| CN-102548993-B | Cyclic (aza)indolizinecarboxamides, their preparation and their use as pharmaceuticals | SANOFI AVENTIS | 2014-12-10 | — | — | CN | disclosed |
| US-8771644-B2 | Imaging probes | SANOFI (FR) | 2014-07-08 | — | — | US | disclosed |
| US-8759067-B2 | Polynucleotides encoding engineered plant cysteine proteases and their uses | CENTOCOR ORTHO BIOTECH INC. (US) | 2014-06-24 | — | — | US | disclosed |
| WO-2014074445-A1 | COMPOSITIONS AND METHODS FOR THE TRANSFER OF A HEXOSAMINE TO A MODIFIED NUCLEOTIDE IN A NUCLEIC ACID | NEW ENGLAND BIOLABS. INC. (US) | 2014-05-15 | — | — | WO | disclosed |
| US-20140127677-A1 | Compositions and Methods for the Transfer of a Hexosamine to a Modified Nucleotide in a Nucleic Acid | NEW ENGLAND BIOLABS, INC. (US) | 2014-05-08 | — | — | US | disclosed |
| US-8663926-B2 | Detection of anthrax pathogenicity factors | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION (US) | 2014-03-04 | — | — | US | disclosed |
| US-20140024039-A1 | METHODS FOR QUANTIFYING MICRORNA PRECURSORS | OHIO STATE INNOVATION FOUNDATION (US) | 2014-01-23 | — | — | US | disclosed |
| US-8623627-B2 | Labelling of fusion proteins with synthetic probes | NEW ENGLAND BIOLABS, INC (US) | 2014-01-07 | — | — | US | disclosed |
| US-8580813-B2 | Cyclic azaindole-3-carboxamides, their preparation and their use as pharmaceuticals | SANOFI (FR) | 2013-11-12 | — | — | US | disclosed |
| EP-2459557-B1 | CYCLIC (AZA)INDOLIZINECARBOXAMIDES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS | SANOFI SA (FR) | 2013-09-18 | — | — | EP | disclosed |
| US-20130196413-A1 | Engineered plant cysteine proteases and their uses | CENTOCOR ORTHO BIOTECH INC. (US) | 2013-08-01 | — | — | US | disclosed |
| EP-2240482-B1 | CYCLIC AZAINDOLE-3-CARBOXAMIDES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS | SANOFI SA (FR) | 2013-07-17 | — | — | EP | disclosed |
| US-20130130291-A1 | Labelling of Fusion Proteins with Synthetic Probes | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH) | 2013-05-23 | — | — | US | disclosed |
| EP-1430147-B1 | FLUORESCENT QUENCHING DETECTION REAGENTS AND METHODS | EPOCH BIOSCIENCES INC (US) | 2013-05-22 | — | — | EP | disclosed |
| US-8426186-B2 | Engineered potato virus A nuclear inclusion protein | CENTOCOR ORTHO BIOTECH INC. (US) | 2013-04-23 | — | — | US | disclosed |
| US-8415336-B2 | Cyclic (aza)indolizinecarboxamides, their preparation and their use as pharmaceuticals | SANOFI (FR) | 2013-04-09 | — | — | US | disclosed |
| US-20120322063-A1 | METHODS FOR QUANTIFYING MICRORNA PRECURSORS | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2012-12-20 | — | — | US | disclosed |
| US-8323886-B2 | Fluorescence methods of detecting a protein-elongation related complex and corollary sequence information | MANDECKI WLODEK (US) | 2012-12-04 | — | — | US | disclosed |
| EP-2049499-B1 | LABELLING OF FUSION PROTEINS WITH SYNTHETIC PROBES | EPFL ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH) | 2012-10-31 | — | — | EP | disclosed |
| EP-2117605-B1 | IMAGING PROBES | SANOFI SA (FR) | 2012-09-26 | — | — | EP | disclosed |
| US-20120237961-A1 | Labelling of Fusion Proteins with Synthetic Probes | GAUTIER ARNAUD (CH) | 2012-09-20 | — | — | US | disclosed |
| US-20120232081-A1 | CYCLIC (AZA)INDOLIZINECARBOXAMIDES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS | SANOFI (FR) | 2012-09-13 | — | — | US | disclosed |
| US-8227602-B2 | Labelling of fusion proteins with synthetic probes | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH) | 2012-07-24 | — | — | US | disclosed |
| US-8211885-B2 | Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals | SANOFI-AVENTIS (FR) | 2012-07-03 | — | — | US | disclosed |
| EP-2459557-A1 | CYCLIC (AZA)INDOLIZINECARBOXAMIDES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS | SANOFI (FR) | 2012-06-06 | — | — | EP | disclosed |
| US-8192938-B2 | Methods for quantifying microRNA precursors | THE OHIO STATE UNIVERSITY (US) | 2012-06-05 | — | — | US | disclosed |
| EP-1945797-B1 | HEPATITIS C VIRUS NS2/3 ACTIVITY ASSAY | BOEHRINGER INGELHEIM INT (DE) | 2012-05-30 | — | — | EP | disclosed |
| US-20120122123-A1 | DETECTION OF ANTHRAX PATHOGENICITY FACTORS | THE GOVERNMENT OF THE US, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2012-05-17 | — | — | US | disclosed |
| US-8163479-B2 | Specific substrates for O6-alkylguanine-DNA alkyltransferase | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH) | 2012-04-24 | — | — | US | disclosed |
| EP-1235938-B1 | FLUORESCENT QUENCHING DETECTION REAGENTS AND METHODS | EPOCH BIOSCIENCES INC (US) | 2012-02-08 | — | — | EP | disclosed |
| US-20110318808-A1 | Engineered Plant Cysteine Proteases and Their Uses | CHI ELLEN (US) | 2011-12-29 | — | — | US | disclosed |
| US-20110207157-A1 | Labelling of Fusion Proteins With Synthetic Probes | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH) | 2011-08-25 | — | — | US | disclosed |
| US-7897736-B2 | Fluorescent quenching detecting reagents and methods | ELITECH HOLDING B.V. (NL) | 2011-03-01 | — | — | US | disclosed |
| US-20110039830-A1 | CYCLIC INDOLE-3-CARBOXAMIDES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS | SANOFI-AVENTIS (FR) | 2011-02-17 | — | — | US | disclosed |
| US-20110039861-A1 | CYCLIC AZAINDOLE-3-CARBOXAMIDES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS | SANOFI-AVENTIS (FR) | 2011-02-17 | — | — | US | disclosed |
| EP-2263799-A2 | Microfabricated reaction chamber system | Norchip A/S (NO) | 2010-12-22 | — | — | EP | disclosed |
| US-20100303728-A1 | CASPASE IMAGING PROBES | SANOFI-AVENTIS (FR) | 2010-12-02 | — | — | US | disclosed |
| EP-2247575-A2 | CYCLIC INDOLE-3-CARBOXAMIDES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS | Sanofi-Aventis (FR) | 2010-11-10 | — | — | EP | disclosed |
| EP-2240482-A1 | CYCLIC AZAINDOLE-3-CARBOXAMIDES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS | Sanofi-Aventis (FR) | 2010-10-20 | — | — | EP | disclosed |
| US-20100189658-A1 | Imaging probes | SANOFI-AVENTIS (FR) | 2010-07-29 | — | — | US | disclosed |
| US-20100174058-A1 | FLUORESCENT QUENCHING DETECTING REAGENTS AND METHODS | ELITECHGROUP, INC. | 2010-07-08 | — | — | US | disclosed |
| EP-2185721-A1 | CASPASE IMAGING PROBES | Sanofi-Aventis (FR) | 2010-05-19 | — | — | EP | disclosed |
| US-7713624-B2 | Luminescent core/shell nanoparticles suitable for (F)RET-assays | BAYER TECHNOLOGY SERVICES GMBH (DE) | 2010-05-11 | — | — | US | disclosed |
| US-7655394-B2 | Selective detection of HCV NS2/3 autocleavage activity hence; identification of potential HCV inhibitor compounds | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-02-02 | — | — | US | disclosed |
| WO-2009095163-A2 | CYCLIC INDOLE-3-CARBOXAMIDES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS | SANOFI-AVENTIS (FR) | 2009-08-06 | — | — | WO | disclosed |
| WO-2009095162-A1 | CYCLIC AZAINDOLE-3-CARBOXAMIDES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS | SANOFI-AVENTIS (FR) | 2009-08-06 | — | — | WO | disclosed |
| EP-1991691-A4 | DETECTION OF ANTHRAX PATHOGENICITY FACTORS | US GOV HEALTH & HUMAN SERV (US) | 2009-07-29 | — | — | EP | disclosed |
| US-20090123917-A1 | METHODS FOR QUANTIFYING MICRORNA PRECURSORS | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2009-05-14 | — | — | US | disclosed |
| EP-2049499-A1 | LABELLING OF FUSION PROTEINS WITH SYNTHETIC PROBES | EPFL Ecole Polytechnique Fédérale de Lausanne (CH) | 2009-04-22 | — | — | EP | disclosed |
| WO-2009019115-A1 | CASPASE IMAGING PROBES | SANOFI-AVENTIS (FR) | 2009-02-12 | — | — | WO | disclosed |
| EP-1991691-A2 | DETECTION OF ANTHRAX PATHOGENICITY FACTORS | The Government of the United States of America, as represented by the Secretary, Department of Health & Human Services (US) | 2008-11-19 | — | — | EP | disclosed |
| US-7410810-B2 | Assay based on doped nanoparticles | BAYER TECHNOLOGY SERVICES GMBH (DE) | 2008-08-12 | — | — | US | disclosed |
| EP-1945797-A1 | HEPATITIS C VIRUS NS2/3 ACTIVITY ASSAY | Boehringer Ingelheim International GmbH (DE) | 2008-07-23 | — | — | EP | disclosed |
| EP-1430147-A4 | FLUORESCENT QUENCHING DETECTION REAGENTS AND METHODS | EPOCH BIOSCIENCES INC (US) | 2008-06-25 | — | — | EP | disclosed |
| US-20080118933-A1 | Methods of screening for inhibitors of antiplasmin cleaving enzyme | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2008-05-22 | — | — | US | disclosed |
| WO-2008012296-A1 | LABELLING OF FUSION PROTEINS WITH SYNTHETIC PROBES | EPFL - ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH) | 2008-01-31 | — | — | WO | disclosed |
| EP-1882688-A1 | Labelling of fusion proteins with synthetic probes | EPFL Ecole Polytechnique Fédérale de Lausanne (CH) | 2008-01-30 | — | — | EP | disclosed |
| US-7309774-B2 | Antiplasmin cleaving enzyme | THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) | 2007-12-18 | — | — | US | disclosed |
| WO-2007136436-A2 | DETECTION OF ANTHRAX PATHOGENICITY FACTORS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF THE HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION (US) | 2007-11-29 | — | — | WO | disclosed |
| US-20070243568-A1 | Specific Substrates for O6-Alkylguanine-Dna Alkyltransferase | EPFL ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH) | 2007-10-18 | — | — | US | disclosed |
| US-20070212754-A1 | Hepatitis C Virus NS2/3 Activity Assay | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2007-09-13 | — | — | US | disclosed |
| WO-2007048254-A1 | HEPATITIS C VIRUS NS2/3 ACTIVITY ASSAY | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2007-05-03 | — | — | WO | disclosed |
| US-20070087195-A1 | Core/shell nanoparticles suitable for(f)ret-assays | NANOSOLUTIONS GMBH (DE) | 2007-04-19 | — | — | US | disclosed |
| WO-2007044057-A2 | METHODS FOR QUANTIFYING MICRORNA PRECURSORS | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2007-04-19 | — | — | WO | disclosed |
| EP-1597360-A4 | ANTIPLASMIN CLEAVING ENZYME | MCKEE PATRICK A (US) | 2006-12-13 | — | — | EP | disclosed |
| EP-1730298-A1 | SPECIFIC SUBSTRATES FOR O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE | EPFL Ecole Polytechnique Fédérale de Lausanne (CH) | 2006-12-13 | — | — | EP | disclosed |
| EP-1473347-B1 | Core/shell nanoparticles suitable for (F) RET-assays | NANOSOLUTIONS GMBH (DE) | 2006-11-29 | — | — | EP | disclosed |
| US-20060229249-A1 | Peptide substrates of a proteolytic ADAM33 polypeptide and assays using the same | SCHERING CORPORATION | 2006-10-12 | — | — | US | disclosed |
| WO-2005085470-A9 | SPECIFIC SUBSTRATES FOR O6- ALKYLGUANINE-DNA ALKYLTRANSFERASE | EPFL ECOLE POLYTECHNIQUE FEDERALE LAUSANNE (CH) | 2006-10-05 | — | — | WO | disclosed |
| US-7067273-B2 | Peptide substrates of a proteolytic ADAM33 polypeptide and assays using the same | SCHERING CORPORATION (US) | 2006-06-27 | — | — | US | disclosed |
| EP-1639093-A2 | MODIFIED MOLECULAR BEACONS | Georgia Tech Research Corporation (US) | 2006-03-29 | — | — | EP | disclosed |
| US-20050282173-A1 | Single molecule fluorescence assay | MANDECKI WLODEK | 2005-12-22 | — | — | US | disclosed |
| EP-1597360-A2 | ANTIPLASMIN CLEAVING ENZYME | McKee, Patrick A. (US) | 2005-11-23 | — | — | EP | disclosed |
| US-6955891-B2 | Reagents for assaying Bacillus anthracis lethal factor protease | MERCK & CO., INC. (US) | 2005-10-18 | — | — | US | disclosed |
| WO-2005085470-A1 | SPECIFIC SUBSTRATES FOR O6- ALKYLGUANINE-DNA ALKYLTRANSFERASE | EPFL ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH) | 2005-09-15 | — | — | WO | disclosed |
| US-20050064604-A1 | Assay based on doped nanoparticles | BAYER TECHNOLOGY SERVICES GMBH | 2005-03-24 | — | — | US | disclosed |
| WO-2005021712-A2 | MODIFIED MOLECULAR BEACONS | GEORGIA TECH RESEARCH CORPORATION (US) | 2005-03-10 | — | — | WO | disclosed |
| EP-1473347-A1 | Core/shell nanoparticles suitable for (F) RET-assays | Nanosolutions GmbH (DE) | 2004-11-03 | — | — | EP | disclosed |
| US-20040203102-A1 | Antiplasmin cleaving enzyme | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2004-10-14 | — | — | US | disclosed |
| WO-2004072240-A2 | ANTIPLASMIN CLEAVING ENZYME | MCKEE PATRICK A (US) | 2004-08-26 | — | — | WO | disclosed |
| US-20040152869-A1 | Peptide substrates of a proteolytic ADAM33 polypeptide and assays using the same | SCHERING CORPORATION | 2004-08-05 | — | — | US | disclosed |
| EP-1430147-A1 | FLUORESCENT QUENCHING DETECTION REAGENTS AND METHODS | Epoch Biosciences, Inc. (US) | 2004-06-23 | — | — | EP | disclosed |
| WO-2002099141-A9 | FLUORESCENT QUENCHING DETECTION REAGENTS AND METHODS | EPOCH BIOSCIENCES INC (US) | 2004-05-27 | — | — | WO | disclosed |
| US-20040081959-A9 | Using oligonucleotide detectors; hybridization analyzing | EPOCH BIOSCIENCES, INC. (US) | 2004-04-29 | — | — | US | disclosed |
| US-6727356-B1 | AS PROBES SUCH AS FOR FLUORESCENCE RESONANCE ENERGY TRANSFER; QUENCHER INCLUDES A 4-(PHENYLDIAZENYL)PHENYLAMINE STRUCTURE; IMPROVED SIGNAL TO NOISE RATIO AND HYBRIDIZATION | EPOCH PHARMACEUTICALS, INC. | 2004-04-27 | — | — | US | disclosed |
| US-6699975-B2 | OLIGONUCLEOTIDE FOR USE AS TOOL IN THE DETECTION OF PREFERENTIAL COMPOUNDS IN SOLUTION | EPOCH BIOSCIENCES, INC. | 2004-03-02 | — | — | US | disclosed |
| US-20040019182-A1 | Reagents and methods for assaying Bacillus anthracis lethal factor protease | MERCK & CO., INC. | 2004-01-29 | — | — | US | disclosed |
| US-6653473-B2 | Nucleotide sequences for use as diagnostic tool in genetic analysis | EPOCH BIOSCIENCES, INC. | 2003-11-25 | — | — | US | disclosed |
| WO-2003073066-A2 | REAGENTS AND METHODS FOR ASSAYING BACILLUS ANTHRACIS LETHAL FACTOR PROTEASE | MERCK & CO., INC. (US) | 2003-09-04 | — | — | WO | disclosed |
| WO-2003055843-A1 | AGARICOGLYCERIDES AND ANALOGS | BAYER HEALTHCARE AG (DE) | 2003-07-10 | — | — | WO | disclosed |
| EP-1317320-A1 | MICROFABRICATED REACTION CHAMBER SYSTEM | Norchip A/S (NO) | 2003-06-11 | — | — | EP | disclosed |
| US-20030096254-A1 | Enhancing resonance ability of oligonuclotide probes for use in hybridization assays; gene expression | EPOCH BIOSCIENCES, INC. (US) | 2003-05-22 | — | — | US | disclosed |
| US-20030008304-A1 | Fluorescent quenching detection reagents and methods | EPOCH BIOSCIENCES, INC. (US) | 2003-01-09 | — | — | US | disclosed |
| WO-2002099141-A1 | FLUORESCENT QUENCHING DETECTION REAGENTS AND METHODS | EPOCH BIOSCIENCES, INC. (US) | 2002-12-12 | — | — | WO | disclosed |
| US-20020155484-A1 | Fluorescent quenching detection reagents and methods | EPOCH PHARMACEUTICALS, INC. (US) | 2002-10-24 | — | — | US | disclosed |
| US-20020102533-A1 | Hepatitis C protease exosite for inhibit or design | BRISTOL-MYERS SQUIBB PHARMA COMPANY (FORMERLY D/B/A DUPONT PHARMACEUTICALS COMPANY) | 2002-08-01 | — | — | US | disclosed |
| WO-2002022265-A1 | MICROFABRICATED REACTION CHAMBER SYSTEM | NORCHIP A/S (NO) | 2002-03-21 | — | — | WO | disclosed |
| WO-2001096540-A2 | HEPATITIS C PROTEASE EXOSITE FOR INHIBITOR DESIGN | DUPONT PHARMACEUTICALS COMPANY (US) | 2001-12-20 | — | — | WO | disclosed |
| US-6194143-B1 | MEASUREMENT ACTIVITY BY MONITORING SUBSTRATE CLEAVAGE | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2001-02-27 | — | — | US | disclosed |
| EP-0948640-A2 | IMPROVED SUBSTRATES FOR HUMAN CYTOMEGALOVIRUS PROTEASE | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 1999-10-13 | — | — | EP | disclosed |
| US-5917012-A | PEPTIDE DERIVATIVES USEFUL FOR THE MEASUREMENT OF PROTEIN PHOSPHATASE ACTIVITY; CONTAINING A FLUORESCENT GROUP, A QUENCHING GROUP AND A PHOSPHORIC ACID GROUP | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 1999-06-29 | — | — | US | disclosed |
| WO-1998029562-A2 | IMPROVED SUBSTRATES FOR HUMAN CYTOMEGALOVIRUS PROTEASE | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 1998-07-09 | — | — | WO | disclosed |
| WO-1998029562-A2 | IMPROVED SUBSTRATES FOR HUMAN CYTOMEGALOVIRUS PROTEASE | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 1998-07-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (20 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180195061-A1 | Methods for Labeling a Population of RNA Molecules | RNGTT, RNMT, MTAP | MAPK1 4662/4885ALDH1A1 2357/4885TSHR 2953/4885 |
| US-20030008304-A1 | Fluorescent quenching detection reagents and methods | DDX5, DDX21, DCLRE1B | MAPK1 4876/4885ALDH1A1 2350/4885TSHR 3247/4885 |
| US-20100189658-A1 | Imaging probes | CTSV, CTSL, CTSB | MAPK1 4088/4885ALDH1A1 816/4885TSHR 2742/4885 |
| US-20110039830-A1 | CYCLIC INDOLE-3-CARBOXAMIDES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS | REN, ACE, PM20D2 | MAPK1 2249/4885ALDH1A1 2427/4885TSHR 1076/4885 |
| US-20180194768-A1 | SUBSTRATE SELECTIVE INHIBITORS OF INSULIN DEGRADING ENZYME (IDE) AND USES THEREOF | IDE, SI, GPR119 | MAPK1 2374/4885ALDH1A1 1439/4885TSHR 1064/4885 |
| US-20100174058-A1 | FLUORESCENT QUENCHING DETECTING REAGENTS AND METHODS | DDX5, DDX21, DCLRE1B | MAPK1 4880/4885ALDH1A1 2211/4885TSHR 2990/4885 |
| US-20040081959-A9 | Using oligonucleotide detectors; hybridization analyzing | DCLRE1B, DDX21, DDX41 | MAPK1 4742/4885ALDH1A1 3725/4885TSHR 1643/4885 |
| US-11396522-B2 | Bis-acetal-based substrates for imaging exo-glycosidase activity | ENGASE, MAN2B2, GALE | MAPK1 4877/4885ALDH1A1 561/4885TSHR 3957/4885 |
| US-20110207157-A1 | Labelling of Fusion Proteins With Synthetic Probes | GART, ALKBH2, ATIC | MAPK1 4169/4885ALDH1A1 1692/4885TSHR 2699/4885 |
| US-20020155484-A1 | Fluorescent quenching detection reagents and methods | IPO4, PTBP3, DDX5 | MAPK1 4212/4885ALDH1A1 3183/4885TSHR 1216/4885 |
| US-20110039861-A1 | CYCLIC AZAINDOLE-3-CARBOXAMIDES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS | REN, PM20D2, CDK20 | MAPK1 2032/4885ALDH1A1 2609/4885TSHR 1502/4885 |
| US-20190016723-A9 | SUBSTRATE SELECTIVE INHIBITORS OF INSULIN-DEGRADING ENZYME (IDE) AND USES THEREOF | IDE, SI, GPR119 | MAPK1 3017/4885ALDH1A1 1194/4885TSHR 1243/4885 |
| US-20070243568-A1 | Specific Substrates for O6-Alkylguanine-Dna Alkyltransferase | AGT, AGXT, AGTR1 | MAPK1 2145/4885ALDH1A1 893/4885TSHR 694/4885 |
| US-11040976-B2 | Substrate selective inhibitors of insulin-degrading enzyme (IDE) and uses thereof | IDE, SI, GPR119 | MAPK1 3017/4885ALDH1A1 1194/4885TSHR 1243/4885 |
| US-20040152869-A1 | Peptide substrates of a proteolytic ADAM33 polypeptide and assays using the same | ADAM33, ADAM17, ADAM12 | MAPK1 2637/4885ALDH1A1 3339/4885TSHR 3149/4885 |
| US-20200207800-A1 | BIS-ACETAL-BASED SUBSTRATES FOR IMAGING EXO-GLYCOSIDASE ACTIVITY | ENGASE, MAN2B2, GALE | MAPK1 4877/4885ALDH1A1 561/4885TSHR 3957/4885 |
| US-20100303728-A1 | CASPASE IMAGING PROBES | CASP1, CASP2, CASP3 | MAPK1 2804/4885ALDH1A1 1759/4885TSHR 4477/4885 |
| US-20120232081-A1 | CYCLIC (AZA)INDOLIZINECARBOXAMIDES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS | REN, ACE, PM20D2 | MAPK1 3211/4885ALDH1A1 2183/4885TSHR 1527/4885 |
| US-20230022745-A1 | Methods for Labeling a Population of RNA Molecules | RNGTT, RNMT, MTAP | MAPK1 4662/4885ALDH1A1 2357/4885TSHR 2953/4885 |
| US-20030096254-A1 | Enhancing resonance ability of oligonuclotide probes for use in hybridization assays; gene expression | DCLRE1B, SNRPE, ZFR | MAPK1 4870/4885ALDH1A1 2641/4885TSHR 1825/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.